Michelle Elizabeth Melisko MD
Breast Cancer, Hematologic Oncology, Hospice & Palliative
Clinical Professor, Medicine, UCSF School of Medicine
Join to View Full Profile
1600 Divisadero StSan Francisco, CA 94143
Phone+1 415-353-7070
Fax+1 415-353-9898
Dr. Melisko is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2000 - 2003
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1997 - 2000
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1997
Certifications & Licensure
CA State Medical License 1998 - 2026
American Board of Internal Medicine Hospice and Palliative Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Irinotecan and Temozolomide in Treating Patients With Breast Cancer Who Have Received Previous Treatment for Brain Metastases Start of enrollment: 2005 Feb 01
- Vaginal Testosterone Cream vs ESTRING for Vaginal Dryness or Decreased Libido in Early Stage Breast Cancer Patients Start of enrollment: 2007 Mar 01
- Comparing (SIS.NET) to Standard Care in Patients Who Have Completed the Acute Phase of Treatment for Early Breast Cancer Start of enrollment: 2011 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsMulticenter retrospective cohort study of the sequential use of the antibody-drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in pa...Laura A Huppert, Reshma Mahtani, Samantha Fisch, Naomi Dempsey, Sarah Premji
NPJ Breast Cancer. 2025-04-15 - System-Level Transformations to Increase Patient Participation in Clinical Trials.Nicole E Caston, Luqin Deng, Courtney P Williams, Emily B Levitan, Andres Azuero
JCO Oncology Practice. 2025-03-13 - Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways.Kate R Oppegaard, Yvette P Conley, Steven Paul, Bruce Cooper, Carolyn S Harris
Journal of Neural Transmission. 2025-02-01
Press Mentions
Brain Metastasis Screening in MBC: Navigating Challenges in Clinical Decision-MakingDecember 16th, 2024- Treating High-Risk, Early-Stage HR+/HER2- Breast CancerApril 29th, 2022
ESMO Breast Cancer Roundtable: Episode 5November 13th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
